Why US-funded vaccine trial plan for babies in Guinea-Bissau caused outrage

Danish researchers were set to begin a controversial United States-funded vaccine trial on newborns in the West African nation of Guinea-Bissau last month when public outrage derailed their plans.

The scientists wanted to assess the effects of administering hepatitis B vaccines at two separate times on 14,000 babies. Half of the sample group, chosen at random, would receive the vaccine at birth ...